13F Filing Secrets 📊 — What Buffett, BlackRock & Goldman Are Really Buying

Every quarter, U.S. institutions with $100M+ in assets pull back the curtain on their portfolios through 13F filings. These snapshots reveal billions in moves — but with a three-month lag. Still, they’re a goldmine for spotting trends and gauging where “smart money” is leaning.

This quarter’s filings show healthcare bets, selective tech rotation, and a mixed stance on China. Here’s the breakdown 👇

---

Big Headlines from Q2 2025

Buffett’s Berkshire Hathaway: Dropped $1.57B into UnitedHealth ($UnitedHealth(UNH)$  ) at ~$314/share, trimmed Apple for the second straight quarter.

Hillhouse Capital: Added to Alibaba $Alibaba(BABA)$  and $MEITUAN(MPNGF)$  , signalling renewed China consumer confidence.

Goldman Sachs: Doubled down on AI-heavy tech names — $NVIDIA(NVDA)$   Microsoft, Broadcom.

BlackRock: Sticking with the Magnificent Seven core holdings, while nibbling at energy and industrials.

---

Why 13F Filings Matter

Think of a 13F as a quarterly treasure map — it doesn’t tell you exactly where the gold is today, but it shows you where the giants were digging recently.

Upside: Insight into conviction trades from the world’s best-resourced teams.

Downside: A 90-day lag means positions may already have changed.

---

Sector Rotations & Themes Emerging

From the Q2 filings, three patterns stand out:

1. Healthcare Rotation 🏥

Buffett’s UNH buy signals confidence in U.S. healthcare resilience amid political noise.

Other funds picked up biotech and insurers — defensive plays with growth optionality.

2. Tech Concentration 💻

Goldman & BlackRock stayed glued to AI chip and cloud leaders.

NVIDIA remains the institutional darling, with few signs of profit-taking despite high valuations.

3. China Risk Appetite 🌏

Hillhouse’s moves contrast with U.S. peers — betting on a consumer recovery in China while others remain cautious.

---

What Could Happen Next (6–12 Month Outlook)

Bull case:

U.S. rate cuts + AI capex boom = tech & healthcare leadership continues.

China stimulus delivers earnings upside for consumer tech.

Bear case:

Sticky inflation forces Fed to hold rates → growth stock multiples compress.

Geopolitical shocks hit China-sensitive names.

---

Investor Takeaways 💡

1. Don’t blindly copy — The 90-day lag can make “fresh” ideas stale. Use filings as research leads, not trade triggers.

2. Spot the clusters — When multiple top funds move into the same sector, that’s worth a deeper dive.

3. Think in themes — 13Fs tell a bigger story about where capital is flowing: AI, healthcare, selective China bets.

4. Check valuations now — A stock bought at $300 in May may be $350 (or $250) today. Context is everything.

---

📈 Your move:

Would you follow Buffett into healthcare now, or focus on the tech names that Goldman and BlackRock are riding? Which 13F trade stands out to you as the smartest play?

@TigerWire  @TigerEvents  @Daily_Discussion  @Tiger_comments  @TigerStars